Cargando...
NYSE: DGX
Operaciones reportadas en formularios SEC Form 4. Las compras se muestran en verde y las ventas en rojo.
| Fecha | Insider | Cargo | Operación | Acciones | Precio | Valor total |
|---|---|---|---|---|---|---|
| 20/04/2026 | Patrick Plewman | SVP for Diagnostic Services | L | 49 | $194,70 | $9,5K |
| 20/04/2026 | Sam Samad | Executive Vice President & CFO | Award | 108 | $194,70 | $21,0K |
| 20/04/2026 | Vicky B Gregg | Director | Award | 68 | $194,70 | $13,2K |
| 20/04/2026 | Wright Lassiter III | Director | L | 6 | $194,70 | $1,2K |
| 20/04/2026 | Mark E Delaney | SVP & Chief Commercial Officer | L | 37 | $194,70 | $7,2K |
| 20/04/2026 | Robert B Carter | Director | L | 7 | $194,70 | $1,4K |
| 20/04/2026 | Karthik Kuppusamy | SVP, Clinical Solutions | L | 39 | $194,70 | $7,6K |
| 01/04/2026 | Timothy C Wentworth | Director | Unknown | 198 | $0,00 | $0 |
| 09/03/2026 | Timothy C Wentworth | Director | Award | 215 | $0,00 | $0 |
| 05/03/2026 | Catherine T. Doherty | EVP, Regional Businesses | Sale | 5.558 | $206,21 | $1,1M |
| 05/03/2026 | Patrick Plewman | SVP for Diagnostic Services | Sale | 2.855 | $206,21 | $588,7K |
| 05/03/2026 | Michael E Prevoznik | SVP & General Counsel | Sale | 3.878 | $206,21 | $799,7K |
| 04/03/2026 | Sam Samad | Executive Vice President & CFO | Award | 13.947 | $204,86 | $2,9M |
| 04/03/2026 | Karthik Kuppusamy | SVP, Clinical Solutions | Sale | 2.628 | $204,86 | $538,4K |
| 04/03/2026 | Mark E Delaney | SVP & Chief Commercial Officer | Award | 5.682 | $204,86 | $1,2M |
| 04/03/2026 | Michael J Deppe | SVP, Corp. Controller & CAO | Tax Withholding | 750 | $204,86 | $153,6K |
| 04/03/2026 | Michael J Deppe | SVP, Corp. Controller & CAO | Award | 1.473 | $204,86 | $301,8K |
| 04/03/2026 | Catherine T. Doherty | EVP, Regional Businesses | Tax Withholding | 5.806 | $204,86 | $1,2M |
| 04/03/2026 | Patrick Plewman | SVP for Diagnostic Services | Award | 5.682 | $204,86 | $1,2M |
| 04/03/2026 | E. J. Davis | CEO and President | Award | 51.652 | $204,86 | $10,6M |
| 04/03/2026 | E. J. Davis | CEO and President | Tax Withholding | 26.414 | $204,86 | $5,4M |
| 04/03/2026 | Patrick Plewman | SVP for Diagnostic Services | Tax Withholding | 2.827 | $204,86 | $579,1K |
| 04/03/2026 | Michael E Prevoznik | SVP & General Counsel | Tax Withholding | 3.354 | $204,86 | $687,1K |
| 04/03/2026 | Sam Samad | Executive Vice President & CFO | Tax Withholding | 7.720 | $204,86 | $1,6M |
| 04/03/2026 | Michael E Prevoznik | SVP & General Counsel | Award | 7.232 | $204,86 | $1,5M |
| 04/03/2026 | Karthik Kuppusamy | SVP, Clinical Solutions | Award | 6.200 | $204,86 | $1,3M |
| 04/03/2026 | Mark E Delaney | SVP & Chief Commercial Officer | Tax Withholding | 2.326 | $204,86 | $476,5K |
| 04/03/2026 | Catherine T. Doherty | EVP, Regional Businesses | Award | 11.364 | $204,86 | $2,3M |
| 03/03/2026 | Catherine T. Doherty | EVP, Regional Businesses | Sale | 632 | $207,73 | $131,3K |
| 03/03/2026 | Patrick Plewman | SVP for Diagnostic Services | Sale | 410 | $207,73 | $85,2K |
| 03/03/2026 | Michael E Prevoznik | SVP & General Counsel | Sale | 526 | $207,73 | $109,3K |
| 02/03/2026 | Sam Samad | Executive Vice President & CFO | Tax Withholding | 869 | $204,86 | $178,0K |
| 02/03/2026 | Michael E Prevoznik | SVP & General Counsel | Tax Withholding | 288 | $204,86 | $59,0K |
| 02/03/2026 | Catherine T. Doherty | EVP, Regional Businesses | Tax Withholding | 648 | $204,86 | $132,7K |
| 02/03/2026 | Michael J Deppe | SVP, Corp. Controller & CAO | Tax Withholding | 88 | $204,86 | $18,0K |
| 02/03/2026 | Mark E Delaney | SVP & Chief Commercial Officer | Tax Withholding | 188 | $204,86 | $38,5K |
| 02/03/2026 | Karthik Kuppusamy | SVP, Clinical Solutions | Tax Withholding | 205 | $204,86 | $42,0K |
| 02/03/2026 | Patrick Plewman | SVP for Diagnostic Services | Tax Withholding | 230 | $204,86 | $47,1K |
| 02/03/2026 | E. J. Davis | CEO and President | Sale | 10.000 | $212,52 | $2,1M |
| 02/03/2026 | E. J. Davis | CEO and President | Tax Withholding | 2.968 | $204,86 | $608,0K |
| 19/02/2026 | Michael E Prevoznik | SVP & General Counsel | Sale | 1.111 | $204,83 | $227,6K |
| 19/02/2026 | Catherine T. Doherty | EVP, Regional Businesses | Sale | 1.433 | $204,83 | $293,5K |
| 19/02/2026 | Patrick Plewman | SVP for Diagnostic Services | Sale | 958 | $204,83 | $196,2K |
| 18/02/2026 | Sam Samad | Executive Vice President & CFO | Unknown | 18.303 | $0,00 | $0 |
| 18/02/2026 | Sam Samad | Executive Vice President & CFO | Tax Withholding | 1.010 | $206,99 | $209,1K |
| 18/02/2026 | Patrick Plewman | SVP for Diagnostic Services | Award | 1.952 | $0,00 | $0 |
| 18/02/2026 | Sam Samad | Executive Vice President & CFO | Tax Withholding | 855 | $210,01 | $179,6K |
| 18/02/2026 | Sam Samad | Executive Vice President & CFO | Award | 3.965 | $0,00 | $0 |
| 18/02/2026 | Patrick Plewman | SVP for Diagnostic Services | Unknown | 9.009 | $0,00 | $0 |
| 18/02/2026 | Patrick Plewman | SVP for Diagnostic Services | Tax Withholding | 293 | $206,99 | $60,6K |
Principales tenedores institucionales por valor de la posición.
| Holder | Tipo | % del flotante | Acciones | Valor | Reportado |
|---|---|---|---|---|---|
| Vanguard Group Inc | Institución | 0,13% | 14.392.082 | $2,7B | 31/12/2025 |
| Blackrock Inc. | Institución | 0,09% | 9.459.218 | $1,8B | 31/12/2025 |
| Price (T.Rowe) Associates Inc | Institución | 0,06% | 6.297.157 | $1,2B | 31/12/2025 |
| State Street Corporation | Institución | 0,05% | 5.382.547 | $1,0B | 31/12/2025 |
| JPMORGAN CHASE & CO | Institución | 0,04% | 4.145.896 | $776,9M | 31/12/2025 |
| Boston Partners | Institución | 0,04% | 3.913.326 | $733,3M | 31/12/2025 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | Fondo | 0,03% | 3.489.557 | $653,9M | 31/12/2025 |
| Geode Capital Management, LLC | Institución | 0,03% | 3.028.207 | $567,5M | 31/12/2025 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | Fondo | 0,03% | 2.805.161 | $525,7M | 31/12/2025 |
| Morgan Stanley | Institución | 0,02% | 2.693.568 | $504,7M | 31/12/2025 |